Ocean Biomedical, Inc.

The momentum for this stock is not very good. Ocean Biomedical, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Ocean Biomedical, Inc..

News

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms

Globe Newswire Figure: 1\n\n Elements of Ocean Biomedical Multi-pronged Malaria Program Testing Result\n\n Figure: 2\n\n Dr. Jonathan Kurtis conducting research near Kisumu, Kenya, one of...\n more…

Ocean Biomedical receives noncompliance notification from Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Ocean Biomedical receives non-compliance notice from Nasdaq

Seeking Alpha - Healthcare Ocean Biomedical receives non-compliance notice from Nasdaq...\n more…

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Globe Newswire PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC...\n more…

Ocean Biomedical congratulates joint venture partner Virion Therapeutics

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON

Globe Newswire Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...\n more…